Joyce DD, Sharma V, Ratcliff GE, Barocas DA, et al. Cost-Effectiveness of Immune Checkpoint Inhibitor Therapy plus BCG for High-Risk Non-muscle Invasive Bladder Cancer: Analyses of CREST, POTOMAC, and ALBAN. J Urol 2026 May 18:101097JU0000000000005126. doi: 10.1097/JU.0000000000005126.
PMID: 42150056